Cargando…
Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma
Autores principales: | Sharma, Sandhya, Perna, Serena K, Mehta, Birju, Lapteva, Natalia, Rouce, Rayne, Ramos, Carlos, Ngo, Minhtran C, Torrano, Vicky, Bollard, Catherine M, Leen, Ann M, Gee, Adrian P, Heslop, Helen, Rooney, Cliona M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646123/ http://dx.doi.org/10.1186/2051-1426-3-S2-P51 |
Ejemplares similares
-
Adoptive transfer of rapidly-generated multivirus-specific T cells to treat Adv, EBV, CMV, BK and HHV6 infections of HSCT recipients
por: Papadopoulou, Anastasia, et al.
Publicado: (2013) -
EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023) -
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells
por: Quach, David H., et al.
Publicado: (2019) -
Identification of protective T-cell antigens for smallpox vaccines
por: Ando, Jun, et al.
Publicado: (2020) -
The impact of HLA class I and EBV latency‐II antigen‐specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma
por: Jones, K., et al.
Publicado: (2015)